// App-Quantinova.ai

Su2082 : Colonic Barrier Function Is Impaired in Post-Campylobacter jejuni Irritable Bowel Syndrome

Researchers

Presenter

  • Gianrico Farrugia

Principal Investigators

  • David R. Linden

  • Duane D. Burton

  • Irene A. Busciglio

  • Michael Camilleri

  • Wallace K. MacNaughton

  • Purna C. Kashyap

  • Kirk Smith

  • Jayne Griffith

  • Anamay N. Sharma

  • Paula Carlson

  • Joseph H. Szurszewski

  • Cheryl E. Bernard

Medical Centers

  • Mayo Clinic, Rochester, MN

  • Minnesota Department of Health, St. Paul, MN

  • University of Calgary, Calgary, AB, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Irritable Bowel Syndrome

  • Constipation

  • Depression

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Acetylcholine

  • Kristalose Oral

  • Dex-HEMA

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved